News & Investors

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

Category: Press Releases

Epigenomics AG to Participate in Raymond James Human Health Innovations Conference

DGAP-News: Epigenomics AG / Key word(s): Conference/Miscellaneous16.06.2020 / 10:00 The issuer is solely responsible for the content of this announcement. Epigenomics AG to Participate in Raymond James Human Health Innovations Conference Berlin (Germany) and San Diego, CA (U.S.A.), June 16, 2020 – Epigenomics AG (FSE: ECX, OTCQX: EPGNY; the “Company”) today announced that company management […]

Read more

Epigenomics AG Reports 2020 First Quarter Financial Results

DGAP-News: Epigenomics AG / Key word(s): Quarterly / Interim Statement/Quarter Results07.05.2020 / 08:17 The issuer is solely responsible for the content of this announcement. Epigenomics AG Reports 2020 First Quarter Financial Results Berlin (Germany) and San Diego, CA (U.S.A.), May 7, 2020 – Epigenomics AG (FSE: ECX, OTCQX: EPGNY, the “Company”) today announced financial results […]

Read more

Epigenomics AG Reports Financial Results for Fiscal Year 2019 and Preliminary Unaudited Financial Results for the First Quarter of 2020

DGAP-News: Epigenomics AG / Key word(s): Annual Results29.04.2020 / 08:00 The issuer is solely responsible for the content of this announcement. Epigenomics AG Reports Financial Results for Fiscal Year 2019 and Preliminary Unaudited Financial Results for the First Quarter of 2020 Berlin (Germany) and San Diego, CA (USA), April 29, 2020 – Epigenomics AG (FSE: […]

Read more

Epigenomics AG: Epi proColon included in 2020 National Comprehensive Cancer Network Colorectal Cancer Screening Guidelines

DGAP-News: Epigenomics AG / Key word(s): Miscellaneous/Scientific publication24.04.2020 / 07:33 The issuer is solely responsible for the content of this announcement. Epigenomics AG: Epi proColon included in 2020 National Comprehensive Cancer Network Colorectal Cancer Screening Guidelines Berlin (Germany), April 24, 2020 – Epigenomics AG (FSE: ECX, OTCQX: EPGNY; the “Company”) announced that Epi proColon, the […]

Read more

Epigenomics AG implements comprehensive measures to reduce costs during the COVID-19 pandemic crisis

DGAP-News: Epigenomics AG / Key word(s): Miscellaneous14.04.2020 / 08:00 The issuer is solely responsible for the content of this announcement. Epigenomics AG implements comprehensive measures to reduce costs during the COVID-19 pandemic crisis Berlin (Germany), April 14, 2020 – Epigenomics AG (FSE: ECX, OTCQX: EPGNY; the “Company”) has initiated comprehensive measures to reduce costs in […]

Read more

Epigenomics Announces Postponement of Annual General Meeting due to Coronavirus and Preliminary 2019 Flash Financial Results

DGAP-News: Epigenomics AG / Key word(s): AGM/EGM/Preliminary Results17.03.2020 / 08:00 The issuer is solely responsible for the content of this announcement. Epigenomics Announces Postponement of Annual General Meeting due to Coronavirus and Preliminary 2019 Flash Financial Results Berlin (Germany), March 17, 2020 – Epigenomics AG (FSE: ECX, OTCQX: EPGNY; the “Company”), today announced the postponement […]

Read more